Silvia Novello
AuthID: R-00F-DA9
1
TITLE: Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)
AUTHORS: Francesco Passiglia; Angela Listì; Paolo Bironzo; Alessandra Merlini; Federica Benso; Francesca Napoli; Francesca Alice Barbu; Vanessa Zambelli; Fabrizio Tabbò; Maria Lucia Reale; Claudio Sini; Elisa Roca; Paola Adriana Taveggia; Francesca Simionato; Lucio Buffoni; Laura Mazilu; Vito Barbieri; Daniele Pignataro; Antonio Araujo; Luis Paz Ares; ...More
PUBLISHED: 2025, SOURCE: Journal of Thoracic Oncology, VOLUME: 20, ISSUE: 5
AUTHORS: Francesco Passiglia; Angela Listì; Paolo Bironzo; Alessandra Merlini; Federica Benso; Francesca Napoli; Francesca Alice Barbu; Vanessa Zambelli; Fabrizio Tabbò; Maria Lucia Reale; Claudio Sini; Elisa Roca; Paola Adriana Taveggia; Francesca Simionato; Lucio Buffoni; Laura Mazilu; Vito Barbieri; Daniele Pignataro; Antonio Araujo; Luis Paz Ares; ...More
PUBLISHED: 2025, SOURCE: Journal of Thoracic Oncology, VOLUME: 20, ISSUE: 5
2
TITLE: Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer Full Text
AUTHORS: Maurice Perol; Nick Pavlakis; Evgeny Levchenko; Marco Platania; Julio Oliveira; Silvia Novello; Rita Chiari; Teresa Moran; Emmanuel Mitry; Eveline Nueesch; Ting Liu; Bogdana Balas; Krzysztof Konopa; Solange Peters;
PUBLISHED: 2019, SOURCE: LUNG CANCER, VOLUME: 138
AUTHORS: Maurice Perol; Nick Pavlakis; Evgeny Levchenko; Marco Platania; Julio Oliveira; Silvia Novello; Rita Chiari; Teresa Moran; Emmanuel Mitry; Eveline Nueesch; Ting Liu; Bogdana Balas; Krzysztof Konopa; Solange Peters;
PUBLISHED: 2019, SOURCE: LUNG CANCER, VOLUME: 138
INDEXED IN: 
WOS
WOS3
TITLE: Safety and Resource Utilization by Non-small Cell Lung Cancer Histology Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaive Patients with Advanced Non-small Cell Lung Cancer
AUTHORS: Silvia Novello; Francisco Luis Pimentel ; Jean Yves Douillard; Mary O'Brien; Joachim von Pawel; John Eckardt; Astra M Liepa; Lorinda Simms; Carla Visseren Grul; Luis Paz Ares;
PUBLISHED: 2010, SOURCE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 5, ISSUE: 10
AUTHORS: Silvia Novello; Francisco Luis Pimentel ; Jean Yves Douillard; Mary O'Brien; Joachim von Pawel; John Eckardt; Astra M Liepa; Lorinda Simms; Carla Visseren Grul; Luis Paz Ares;
PUBLISHED: 2010, SOURCE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 5, ISSUE: 10
INDEXED IN: 
Scopus WOS
Scopus WOS4
TITLE: Safety and Resource Utilization by Non-small Cell Lung Cancer Histology. Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaïve Patients with Advanced Non-small Cell Lung Cancer
AUTHORS: Silvia Novello; Francisco Luis Pimentel; Jean-Yves Douillard; Mary OʼBrien; Joachim von Pawel; John Eckardt; Astra M Liepa; Lorinda Simms; Carla Visseren-Grul; Luis Paz-Ares;
PUBLISHED: 2010, SOURCE: Journal of Thoracic Oncology, VOLUME: 5, ISSUE: 10
AUTHORS: Silvia Novello; Francisco Luis Pimentel; Jean-Yves Douillard; Mary OʼBrien; Joachim von Pawel; John Eckardt; Astra M Liepa; Lorinda Simms; Carla Visseren-Grul; Luis Paz-Ares;
PUBLISHED: 2010, SOURCE: Journal of Thoracic Oncology, VOLUME: 5, ISSUE: 10
